Cargando…

A preliminary study of peripheral T‐cell subsets in porokeratosis patients with MVK or MVD variants

BACKGROUND: Porokeratosis (PK) is considered a skin‐specific autoinflammatory keratinization disease. Intriguingly, four causative genes of PK are in turn arranged in mevalonate pathway, with MVD variants being the commonest followed by MVK variants in a cohort of Chinese patients. Evidence indicate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, L., Huang, Y. K., Yan, K. X., Li, C. H., Shen, L., Zhang, Z. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060116/
https://www.ncbi.nlm.nih.gov/pubmed/35665211
http://dx.doi.org/10.1002/ski2.82
_version_ 1784698451036995584
author Tao, L.
Huang, Y. K.
Yan, K. X.
Li, C. H.
Shen, L.
Zhang, Z. H.
author_facet Tao, L.
Huang, Y. K.
Yan, K. X.
Li, C. H.
Shen, L.
Zhang, Z. H.
author_sort Tao, L.
collection PubMed
description BACKGROUND: Porokeratosis (PK) is considered a skin‐specific autoinflammatory keratinization disease. Intriguingly, four causative genes of PK are in turn arranged in mevalonate pathway, with MVD variants being the commonest followed by MVK variants in a cohort of Chinese patients. Evidence indicates that mevalonate metabolites induce trained immunity in human monocytes and regulate T cells at multiple levels. Of note, γδT cells are dually regulated by intracellular and extracellular mevalonate metabolism. AIMS: To identify the possible differences in T‐cell between MVK or MVD variants from PK patients. MATERIALS & METHODS: Targeted exome sequencing and exonic CNV screening were performed in 26 patients with PK. Sanger sequencing was used to validate all identified variants. Among them, 22 patients were identified with MVK or MVD variants. PBMCs from 22 PK patients and 27 normal controls (NCs) were analysed by flow cytometry for the frequencies of T cells subsets, including IFN‐γ‐, and TNF‐α‐producing T cells. RESULTS: There were 14 mutations identified in the 26 PK patients, including 6 novel mutations (MVK: c.118_226+1337dup, c.388_392delGATATinsC, c.613A>T, c.768G>C, and MVD: c.250C>T, c.988T>G). In contrast to NCs, significantly decreased frequencies of CD8(+) and Vγ9Vδ2 T cells were observed in the PK patients with MVD variants. Moreover, it was found that dysregulated secretion of pro‐inflammatory cytokines by T cells in both PK patients with MVK and MVD variants. CONCLUSIONS: Our findings enriched the Human Gene Mutation Databases and showed probable differences in peripheral T cells subsets between PK patients and controls.
format Online
Article
Text
id pubmed-9060116
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90601162022-06-04 A preliminary study of peripheral T‐cell subsets in porokeratosis patients with MVK or MVD variants Tao, L. Huang, Y. K. Yan, K. X. Li, C. H. Shen, L. Zhang, Z. H. Skin Health Dis Original Articles BACKGROUND: Porokeratosis (PK) is considered a skin‐specific autoinflammatory keratinization disease. Intriguingly, four causative genes of PK are in turn arranged in mevalonate pathway, with MVD variants being the commonest followed by MVK variants in a cohort of Chinese patients. Evidence indicates that mevalonate metabolites induce trained immunity in human monocytes and regulate T cells at multiple levels. Of note, γδT cells are dually regulated by intracellular and extracellular mevalonate metabolism. AIMS: To identify the possible differences in T‐cell between MVK or MVD variants from PK patients. MATERIALS & METHODS: Targeted exome sequencing and exonic CNV screening were performed in 26 patients with PK. Sanger sequencing was used to validate all identified variants. Among them, 22 patients were identified with MVK or MVD variants. PBMCs from 22 PK patients and 27 normal controls (NCs) were analysed by flow cytometry for the frequencies of T cells subsets, including IFN‐γ‐, and TNF‐α‐producing T cells. RESULTS: There were 14 mutations identified in the 26 PK patients, including 6 novel mutations (MVK: c.118_226+1337dup, c.388_392delGATATinsC, c.613A>T, c.768G>C, and MVD: c.250C>T, c.988T>G). In contrast to NCs, significantly decreased frequencies of CD8(+) and Vγ9Vδ2 T cells were observed in the PK patients with MVD variants. Moreover, it was found that dysregulated secretion of pro‐inflammatory cytokines by T cells in both PK patients with MVK and MVD variants. CONCLUSIONS: Our findings enriched the Human Gene Mutation Databases and showed probable differences in peripheral T cells subsets between PK patients and controls. John Wiley and Sons Inc. 2021-12-16 /pmc/articles/PMC9060116/ /pubmed/35665211 http://dx.doi.org/10.1002/ski2.82 Text en © 2021 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Tao, L.
Huang, Y. K.
Yan, K. X.
Li, C. H.
Shen, L.
Zhang, Z. H.
A preliminary study of peripheral T‐cell subsets in porokeratosis patients with MVK or MVD variants
title A preliminary study of peripheral T‐cell subsets in porokeratosis patients with MVK or MVD variants
title_full A preliminary study of peripheral T‐cell subsets in porokeratosis patients with MVK or MVD variants
title_fullStr A preliminary study of peripheral T‐cell subsets in porokeratosis patients with MVK or MVD variants
title_full_unstemmed A preliminary study of peripheral T‐cell subsets in porokeratosis patients with MVK or MVD variants
title_short A preliminary study of peripheral T‐cell subsets in porokeratosis patients with MVK or MVD variants
title_sort preliminary study of peripheral t‐cell subsets in porokeratosis patients with mvk or mvd variants
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060116/
https://www.ncbi.nlm.nih.gov/pubmed/35665211
http://dx.doi.org/10.1002/ski2.82
work_keys_str_mv AT taol apreliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT huangyk apreliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT yankx apreliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT lich apreliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT shenl apreliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT zhangzh apreliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT taol preliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT huangyk preliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT yankx preliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT lich preliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT shenl preliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants
AT zhangzh preliminarystudyofperipheraltcellsubsetsinporokeratosispatientswithmvkormvdvariants